Stock markets in Asia are mixed today following the widely-expected results of the first round of presidential elections in France. The Shanghai Composite is off 1.50%, while the Hang Seng is down 0.29%. The Nikkei 225 is trading higher by 1.32%. The US stocks closed lower in choppy trade on Friday after Trump told the Associated Press he would be releasing a massive tax cut package in the coming week.

Meanwhile, share markets in India have opened the day on a positive note. The BSE Sensex is trading up by 82 points while the NSE Nifty is trading up by 15 points. The BSE Mid Cap index and BSE Small Cap index have opened the day up by 0.4% & 0.5% respectively.

Barring stocks from information technology sector and healthcare sector, all the sectoral indices have opened the day in green with stocks from realty sector, capital goods sector and banking sector leading the gains. The rupee is trading at 64.57 to the US$.

Pharma stocks opened the day on a mixed note with Elder Pharma and Panacea Biotech witnessing maximum buying interest. As per an article in The Economic Times, Dr. Reddy’s Laboratories Ltd (RDY) announced that it has launched Progesterone Capsules, 100 mg and 200 mg. The capsules are a therapeutic equivalent generic version of Prometrium (Progesterone) Capsules in the United States market.

The product has been approved by the US health regulator, United States Food and Drug Administration (USFDA). Prometrium is a registered trademark of Abbvie Products LLC in the US.

According to the IMS Health sales data, the Prometrium brand and its generic capsules had sales valued at US$153 million across the US in 12 months ending February.

In the meanwhile, the USFDA has issued a Warning Letter for Divi’s Laboratories Limited’s Unit-II at Visakhapatnam. Divi’s has responded to the observations with an appropriate remediation process to overcome the deficiencies observed, and also provided periodic updates to the agency, the reports noted.